Remission of proteinuria in multidrug-resistant idiopathic nephrotic syndrome following immunoglobulin
Elodie Nattes1, Danièle Karaa1, Laurène Dehoux1
1Pediatric Nephrology Unit, Hôpital Robert Debré, APHP, Sorbonne Paris Cité University, Paris, France.
Insights
Multidrug-resistant nephrotic syndrome in children can be treated with immunoglobulin immunoadsorption (IgIA) and B-cell depletion, achieving remission in most patients. However, sustained remission often requires additional immunosuppression.
Area of Science:
- Pediatric Nephrology
- Immunology
Background:
- Idiopathic nephrotic syndrome (INS) resistant to standard treatments like prednisone and calcineurin inhibitors can progress to end-stage renal disease.
- Multidrug-resistant INS poses a significant therapeutic challenge in pediatric patients.
Purpose of the Study:
- To evaluate the efficacy of a treatment combining immunoglobulin immunoadsorption (IgIA), intravenous immunoglobulins, and B-cell depletion for multidrug-resistant nephrotic syndrome in children.
- To report the outcomes and remission rates in this patient cohort.
Main Methods:
- Patients underwent ten sessions of IgIA and intravenous immunoglobulins over two weeks.
- Rituximab was administered for patients achieving remission.
- Treatment outcomes, including proteinuria remission and relapse rates, were monitored.
Main Results:
- Remission of proteinuria was achieved in 9 out of 14 patients after the initial phase, with 2 additional patients responding after extended treatment.
- Remission was stable in 3 patients and maintained with additional IgIA and immunosuppression in 6 patients.
- Two patients relapsed after IgIA withdrawal, and 3 patients (including 2 with genetic podocytopathy) did not respond to treatment.
Conclusions:
- Immunoglobulin immunoadsorption (IgIA) can induce remission in children with multidrug-resistant nephrotic syndrome, potentially preventing progression to end-stage renal disease.
- Achieving and maintaining remission often necessitates significant additional immunosuppressive therapy.
Aim:
Complete or partial resistance to prednisone and calcineurin inhibitors in children with idiopathic nephrotic syndrome often leads to end-stage renal disease. The aim of the study was to report the outcome of patients with multidrug-resistant nephrotic syndrome treated with an association of immunoglobulin immunoadsorption, intravenous immunoglobulins and B-cell depletion.
Methods:
At treatment initiation, patients received ten sessions of immunoglobulin immunoadsorption and intravenous immunoglobulins in two weeks followed by one rituximab in case of remission.
Results:
A remission of proteinuria was obtained in nine out of 14 patients at the end of the initial phase and in two additional patients after an extended period. The remission was stable in three patients and after additional IgIA and heavy immunosuppression in six. Two patients that initially responded relapsed after IgIA withdrawal and remained with an uncontrolled disease at last follow-up. Three patients did not respond to the treatment including two who were found to have a genetic podocytopathy.
Conclusion:
Patients with multidrug-resistant idiopathic nephrotic syndrome can be successfully led into remission by IgIA prior to reaching end-stage renal disease. However, IgIA does not suppress the need for heavy additional immunosuppression to control INS in most cases.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
23:06The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Resistivity
Resistance
